|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Deferred offering costs | ||||||||||
| Due from related party | ||||||||||
| Cash | ||||||||||
| Prepaid expenses | ||||||||||
| Total current assets | ||||||||||
| Prepaid expenses – non-current portion | ||||||||||
| Cash and Investments held in trust account | ||||||||||
| Total Assets | ||||||||||
| Current Liabilities | ||||||||||
| Accounts payable and accrued expenses | ||||||||||
| Income taxes payable | ||||||||||
| Excise tax payable | ||||||||||
| Promissory note – related party | ||||||||||
| Total Current liabilities | ||||||||||
| Deferred underwriters’ discount | ||||||||||
| Total Liabilities | ||||||||||
| Common stock subject to redemption, 3,466,135 shares at redemption value of $10.30 and $10.02 as of June 30, 2023 and December 31, 2022, respectively. | ||||||||||
| Common stock subject to redemption, 2,597,265 and 3,466,135 shares at redemption value of $10.38 and $10.02 as of September 30, 2023 and December 31, 2022, respectively. | ||||||||||
| Stockholders’ Deficit | ||||||||||
| Common stock, $0.0001 par value; 100,000,000 shares authorized; 5,750,000 shares issued and outstanding (excluding 2,597,265 and 3,466,135 shares subject to possible redemption) | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Total Stockholders’ Deficit | ||||||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
